The global market for Chronic Urticaria Or Hives Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Chronic Urticaria Or Hives Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Urticaria Or Hives Drug.

The Chronic Urticaria Or Hives Drug market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chronic Urticaria Or Hives Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Chronic Urticaria Or Hives Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Chronic Urticaria Or Hives Drug Market Report

Report Metric	Details
Report Name	Chronic Urticaria Or Hives Drug Market
CAGR	5%
Segment by Type	GDC-0853 GSK-2646264 BF-Derm-1 Bilastine Others
Segment by Application	Clinic Hospital Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	AstraZeneca Plc, Biofrontera AG, ELORAC, Inc., Faes Farma, SA, Genentech, Inc., GlaxoSmithKline Plc, J Uriach Y Compania, S.A., Mabtech Limited, Merck & Co., Inc., Mycenax Biotech Inc., Novartis AG, Panacea Biotec Limited
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Chronic Urticaria Or Hives Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Chronic Urticaria Or Hives Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Chronic Urticaria Or Hives Drug Market report?

Ans: The main players in the Chronic Urticaria Or Hives Drug Market are AstraZeneca Plc, Biofrontera AG, ELORAC, Inc., Faes Farma, SA, Genentech, Inc., GlaxoSmithKline Plc, J Uriach Y Compania, S.A., Mabtech Limited, Merck & Co., Inc., Mycenax Biotech Inc., Novartis AG, Panacea Biotec Limited

What are the Application segmentation covered in the Chronic Urticaria Or Hives Drug Market report?

Ans: The Applications covered in the Chronic Urticaria Or Hives Drug Market report are Clinic, Hospital, Others

What are the Type segmentation covered in the Chronic Urticaria Or Hives Drug Market report?

Ans: The Types covered in the Chronic Urticaria Or Hives Drug Market report are GDC-0853, GSK-2646264, BF-Derm-1, Bilastine, Others

1 Chronic Urticaria Or Hives Drug Market Overview

1.1 Product Definition

1.2 Chronic Urticaria Or Hives Drug by Type

1.2.1 Global Chronic Urticaria Or Hives Drug Market Value Comparison by Type (2024 VS 2031)

1.2.2 GDC-0853

1.2.3 GSK-2646264

1.2.4 BF-Derm-1

1.2.5 Bilastine

1.2.6 Others

1.3 Chronic Urticaria Or Hives Drug by Application

1.3.1 Global Chronic Urticaria Or Hives Drug Market Value by Application (2024 VS 2031)

1.3.2 Clinic

1.3.3 Hospital

1.3.4 Others

1.4 Global Chronic Urticaria Or Hives Drug Market Size Estimates and Forecasts

1.4.1 Global Chronic Urticaria Or Hives Drug Revenue 2020-2031

1.4.2 Global Chronic Urticaria Or Hives Drug Sales 2020-2031

1.4.3 Global Chronic Urticaria Or Hives Drug Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Chronic Urticaria Or Hives Drug Market Competition by Manufacturers

2.1 Global Chronic Urticaria Or Hives Drug Sales Market Share by Manufacturers (2020-2025)

2.2 Global Chronic Urticaria Or Hives Drug Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Chronic Urticaria Or Hives Drug Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Chronic Urticaria Or Hives Drug, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Chronic Urticaria Or Hives Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Chronic Urticaria Or Hives Drug, Product Type & Application

2.7 Global Key Manufacturers of Chronic Urticaria Or Hives Drug, Date of Enter into This Industry

2.8 Global Chronic Urticaria Or Hives Drug Market Competitive Situation and Trends

2.8.1 Global Chronic Urticaria Or Hives Drug Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Chronic Urticaria Or Hives Drug Players Market Share by Revenue

2.8.3 Global Chronic Urticaria Or Hives Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Chronic Urticaria Or Hives Drug Market Scenario by Region

3.1 Global Chronic Urticaria Or Hives Drug Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Chronic Urticaria Or Hives Drug Sales by Region: 2020-2031

3.2.1 Global Chronic Urticaria Or Hives Drug Sales by Region: 2020-2025

3.2.2 Global Chronic Urticaria Or Hives Drug Sales by Region: 2026-2031

3.3 Global Chronic Urticaria Or Hives Drug Revenue by Region: 2020-2031

3.3.1 Global Chronic Urticaria Or Hives Drug Revenue by Region: 2020-2025

3.3.2 Global Chronic Urticaria Or Hives Drug Revenue by Region: 2026-2031

3.4 North America Chronic Urticaria Or Hives Drug Market Facts & Figures by Country

3.4.1 North America Chronic Urticaria Or Hives Drug Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Chronic Urticaria Or Hives Drug Sales by Country (2020-2031)

3.4.3 North America Chronic Urticaria Or Hives Drug Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Chronic Urticaria Or Hives Drug Market Facts & Figures by Country

3.5.1 Europe Chronic Urticaria Or Hives Drug Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Chronic Urticaria Or Hives Drug Sales by Country (2020-2031)

3.5.3 Europe Chronic Urticaria Or Hives Drug Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Chronic Urticaria Or Hives Drug Market Facts & Figures by Region

3.6.1 Asia Pacific Chronic Urticaria Or Hives Drug Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Chronic Urticaria Or Hives Drug Sales by Region (2020-2031)

3.6.3 Asia Pacific Chronic Urticaria Or Hives Drug Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Chronic Urticaria Or Hives Drug Market Facts & Figures by Country

3.7.1 Latin America Chronic Urticaria Or Hives Drug Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Chronic Urticaria Or Hives Drug Sales by Country (2020-2031)

3.7.3 Latin America Chronic Urticaria Or Hives Drug Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Chronic Urticaria Or Hives Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Chronic Urticaria Or Hives Drug Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Chronic Urticaria Or Hives Drug Sales by Country (2020-2031)

3.8.3 Middle East and Africa Chronic Urticaria Or Hives Drug Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Chronic Urticaria Or Hives Drug Sales by Type (2020-2031)

4.1.1 Global Chronic Urticaria Or Hives Drug Sales by Type (2020-2025)

4.1.2 Global Chronic Urticaria Or Hives Drug Sales by Type (2026-2031)

4.1.3 Global Chronic Urticaria Or Hives Drug Sales Market Share by Type (2020-2031)

4.2 Global Chronic Urticaria Or Hives Drug Revenue by Type (2020-2031)

4.2.1 Global Chronic Urticaria Or Hives Drug Revenue by Type (2020-2025)

4.2.2 Global Chronic Urticaria Or Hives Drug Revenue by Type (2026-2031)

4.2.3 Global Chronic Urticaria Or Hives Drug Revenue Market Share by Type (2020-2031)

4.3 Global Chronic Urticaria Or Hives Drug Price by Type (2020-2031)

5 Segment by Application

5.1 Global Chronic Urticaria Or Hives Drug Sales by Application (2020-2031)

5.1.1 Global Chronic Urticaria Or Hives Drug Sales by Application (2020-2025)

5.1.2 Global Chronic Urticaria Or Hives Drug Sales by Application (2026-2031)

5.1.3 Global Chronic Urticaria Or Hives Drug Sales Market Share by Application (2020-2031)

5.2 Global Chronic Urticaria Or Hives Drug Revenue by Application (2020-2031)

5.2.1 Global Chronic Urticaria Or Hives Drug Revenue by Application (2020-2025)

5.2.2 Global Chronic Urticaria Or Hives Drug Revenue by Application (2026-2031)

5.2.3 Global Chronic Urticaria Or Hives Drug Revenue Market Share by Application (2020-2031)

5.3 Global Chronic Urticaria Or Hives Drug Price by Application (2020-2031)

6 Key Companies Profiled

6.1 AstraZeneca Plc

6.1.1 AstraZeneca Plc Company Information

6.1.2 AstraZeneca Plc Description and Business Overview

6.1.3 AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2020-2025)

6.1.4 AstraZeneca Plc Chronic Urticaria Or Hives Drug Product Portfolio

6.1.5 AstraZeneca Plc Recent Developments/Updates

6.2 Biofrontera AG

6.2.1 Biofrontera AG Company Information

6.2.2 Biofrontera AG Description and Business Overview

6.2.3 Biofrontera AG Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Biofrontera AG Chronic Urticaria Or Hives Drug Product Portfolio

6.2.5 Biofrontera AG Recent Developments/Updates

6.3 ELORAC, Inc.

6.3.1 ELORAC, Inc. Company Information

6.3.2 ELORAC, Inc. Description and Business Overview

6.3.3 ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2020-2025)

6.3.4 ELORAC, Inc. Chronic Urticaria Or Hives Drug Product Portfolio

6.3.5 ELORAC, Inc. Recent Developments/Updates

6.4 Faes Farma, SA

6.4.1 Faes Farma, SA Company Information

6.4.2 Faes Farma, SA Description and Business Overview

6.4.3 Faes Farma, SA Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Faes Farma, SA Chronic Urticaria Or Hives Drug Product Portfolio

6.4.5 Faes Farma, SA Recent Developments/Updates

6.5 Genentech, Inc.

6.5.1 Genentech, Inc. Company Information

6.5.2 Genentech, Inc. Description and Business Overview

6.5.3 Genentech, Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Genentech, Inc. Chronic Urticaria Or Hives Drug Product Portfolio

6.5.5 Genentech, Inc. Recent Developments/Updates

6.6 GlaxoSmithKline Plc

6.6.1 GlaxoSmithKline Plc Company Information

6.6.2 GlaxoSmithKline Plc Description and Business Overview

6.6.3 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2020-2025)

6.6.4 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Product Portfolio

6.6.5 GlaxoSmithKline Plc Recent Developments/Updates

6.7 J Uriach Y Compania, S.A.

6.7.1 J Uriach Y Compania, S.A. Company Information

6.7.2 J Uriach Y Compania, S.A. Description and Business Overview

6.7.3 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2020-2025)

6.7.4 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Product Portfolio

6.7.5 J Uriach Y Compania, S.A. Recent Developments/Updates

6.8 Mabtech Limited

6.8.1 Mabtech Limited Company Information

6.8.2 Mabtech Limited Description and Business Overview

6.8.3 Mabtech Limited Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Mabtech Limited Chronic Urticaria Or Hives Drug Product Portfolio

6.8.5 Mabtech Limited Recent Developments/Updates

6.9 Merck & Co., Inc.

6.9.1 Merck & Co., Inc. Company Information

6.9.2 Merck & Co., Inc. Description and Business Overview

6.9.3 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Product Portfolio

6.9.5 Merck & Co., Inc. Recent Developments/Updates

6.10 Mycenax Biotech Inc.

6.10.1 Mycenax Biotech Inc. Company Information

6.10.2 Mycenax Biotech Inc. Description and Business Overview

6.10.3 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Product Portfolio

6.10.5 Mycenax Biotech Inc. Recent Developments/Updates

6.11 Novartis AG

6.11.1 Novartis AG Company Information

6.11.2 Novartis AG Description and Business Overview

6.11.3 Novartis AG Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Novartis AG Chronic Urticaria Or Hives Drug Product Portfolio

6.11.5 Novartis AG Recent Developments/Updates

6.12 Panacea Biotec Limited

6.12.1 Panacea Biotec Limited Company Information

6.12.2 Panacea Biotec Limited Description and Business Overview

6.12.3 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Product Portfolio

6.12.5 Panacea Biotec Limited Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Chronic Urticaria Or Hives Drug Industry Chain Analysis

7.2 Chronic Urticaria Or Hives Drug Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Chronic Urticaria Or Hives Drug Production Mode & Process Analysis

7.4 Chronic Urticaria Or Hives Drug Sales and Marketing

7.4.1 Chronic Urticaria Or Hives Drug Sales Channels

7.4.2 Chronic Urticaria Or Hives Drug Distributors

7.5 Chronic Urticaria Or Hives Drug Customer Analysis

8 Chronic Urticaria Or Hives Drug Market Dynamics

8.1 Chronic Urticaria Or Hives Drug Industry Trends

8.2 Chronic Urticaria Or Hives Drug Market Drivers

8.3 Chronic Urticaria Or Hives Drug Market Challenges

8.4 Chronic Urticaria Or Hives Drug Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

J Uriach Y Compania, S.A.

Panacea Biotec Limited

List of Tables

Table 1. Global Chronic Urticaria Or Hives Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Chronic Urticaria Or Hives Drug Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Chronic Urticaria Or Hives Drug Market Competitive Situation by Manufacturers in 2024

Table 4. Global Chronic Urticaria Or Hives Drug Sales (K Pcs) of Key Manufacturers (2020-2025)

Table 5. Global Chronic Urticaria Or Hives Drug Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Chronic Urticaria Or Hives Drug Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Chronic Urticaria Or Hives Drug Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Chronic Urticaria Or Hives Drug Average Price (USD/Pcs) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Chronic Urticaria Or Hives Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Chronic Urticaria Or Hives Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Chronic Urticaria Or Hives Drug, Product Type & Application

Table 12. Global Key Manufacturers of Chronic Urticaria Or Hives Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Chronic Urticaria Or Hives Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Urticaria Or Hives Drug as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Chronic Urticaria Or Hives Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Chronic Urticaria Or Hives Drug Sales by Region (2020-2025) & (K Pcs)

Table 18. Global Chronic Urticaria Or Hives Drug Sales Market Share by Region (2020-2025)

Table 19. Global Chronic Urticaria Or Hives Drug Sales by Region (2026-2031) & (K Pcs)

Table 20. Global Chronic Urticaria Or Hives Drug Sales Market Share by Region (2026-2031)

Table 21. Global Chronic Urticaria Or Hives Drug Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Region (2020-2025)

Table 23. Global Chronic Urticaria Or Hives Drug Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Region (2026-2031)

Table 25. North America Chronic Urticaria Or Hives Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Chronic Urticaria Or Hives Drug Sales by Country (2020-2025) & (K Pcs)

Table 27. North America Chronic Urticaria Or Hives Drug Sales by Country (2026-2031) & (K Pcs)

Table 28. North America Chronic Urticaria Or Hives Drug Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Chronic Urticaria Or Hives Drug Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Chronic Urticaria Or Hives Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Chronic Urticaria Or Hives Drug Sales by Country (2020-2025) & (K Pcs)

Table 32. Europe Chronic Urticaria Or Hives Drug Sales by Country (2026-2031) & (K Pcs)

Table 33. Europe Chronic Urticaria Or Hives Drug Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Chronic Urticaria Or Hives Drug Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Chronic Urticaria Or Hives Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Chronic Urticaria Or Hives Drug Sales by Region (2020-2025) & (K Pcs)

Table 37. Asia Pacific Chronic Urticaria Or Hives Drug Sales by Region (2026-2031) & (K Pcs)

Table 38. Asia Pacific Chronic Urticaria Or Hives Drug Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Chronic Urticaria Or Hives Drug Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Chronic Urticaria Or Hives Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Chronic Urticaria Or Hives Drug Sales by Country (2020-2025) & (K Pcs)

Table 42. Latin America Chronic Urticaria Or Hives Drug Sales by Country (2026-2031) & (K Pcs)

Table 43. Latin America Chronic Urticaria Or Hives Drug Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Chronic Urticaria Or Hives Drug Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Chronic Urticaria Or Hives Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Chronic Urticaria Or Hives Drug Sales by Country (2020-2025) & (K Pcs)

Table 47. Middle East and Africa Chronic Urticaria Or Hives Drug Sales by Country (2026-2031) & (K Pcs)

Table 48. Middle East and Africa Chronic Urticaria Or Hives Drug Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Chronic Urticaria Or Hives Drug Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Chronic Urticaria Or Hives Drug Sales (K Pcs) by Type (2020-2025)

Table 51. Global Chronic Urticaria Or Hives Drug Sales (K Pcs) by Type (2026-2031)

Table 52. Global Chronic Urticaria Or Hives Drug Sales Market Share by Type (2020-2025)

Table 53. Global Chronic Urticaria Or Hives Drug Sales Market Share by Type (2026-2031)

Table 54. Global Chronic Urticaria Or Hives Drug Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Chronic Urticaria Or Hives Drug Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Type (2020-2025)

Table 57. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Type (2026-2031)

Table 58. Global Chronic Urticaria Or Hives Drug Price (USD/Pcs) by Type (2020-2025)

Table 59. Global Chronic Urticaria Or Hives Drug Price (USD/Pcs) by Type (2026-2031)

Table 60. Global Chronic Urticaria Or Hives Drug Sales (K Pcs) by Application (2020-2025)

Table 61. Global Chronic Urticaria Or Hives Drug Sales (K Pcs) by Application (2026-2031)

Table 62. Global Chronic Urticaria Or Hives Drug Sales Market Share by Application (2020-2025)

Table 63. Global Chronic Urticaria Or Hives Drug Sales Market Share by Application (2026-2031)

Table 64. Global Chronic Urticaria Or Hives Drug Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Chronic Urticaria Or Hives Drug Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Application (2020-2025)

Table 67. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Application (2026-2031)

Table 68. Global Chronic Urticaria Or Hives Drug Price (USD/Pcs) by Application (2020-2025)

Table 69. Global Chronic Urticaria Or Hives Drug Price (USD/Pcs) by Application (2026-2031)

Table 70. AstraZeneca Plc Company Information

Table 71. AstraZeneca Plc Description and Business Overview

Table 72. AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 73. AstraZeneca Plc Chronic Urticaria Or Hives Drug Product

Table 74. AstraZeneca Plc Recent Developments/Updates

Table 75. Biofrontera AG Company Information

Table 76. Biofrontera AG Description and Business Overview

Table 77. Biofrontera AG Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 78. Biofrontera AG Chronic Urticaria Or Hives Drug Product

Table 79. Biofrontera AG Recent Developments/Updates

Table 80. ELORAC, Inc. Company Information

Table 81. ELORAC, Inc. Description and Business Overview

Table 82. ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 83. ELORAC, Inc. Chronic Urticaria Or Hives Drug Product

Table 84. ELORAC, Inc. Recent Developments/Updates

Table 85. Faes Farma, SA Company Information

Table 86. Faes Farma, SA Description and Business Overview

Table 87. Faes Farma, SA Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 88. Faes Farma, SA Chronic Urticaria Or Hives Drug Product

Table 89. Faes Farma, SA Recent Developments/Updates

Table 90. Genentech, Inc. Company Information

Table 91. Genentech, Inc. Description and Business Overview

Table 92. Genentech, Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 93. Genentech, Inc. Chronic Urticaria Or Hives Drug Product

Table 94. Genentech, Inc. Recent Developments/Updates

Table 95. GlaxoSmithKline Plc Company Information

Table 96. GlaxoSmithKline Plc Description and Business Overview

Table 97. GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 98. GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Product

Table 99. GlaxoSmithKline Plc Recent Developments/Updates

Table 100. J Uriach Y Compania, S.A. Company Information

Table 101. J Uriach Y Compania, S.A. Description and Business Overview

Table 102. J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 103. J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Product

Table 104. J Uriach Y Compania, S.A. Recent Developments/Updates

Table 105. Mabtech Limited Company Information

Table 106. Mabtech Limited Description and Business Overview

Table 107. Mabtech Limited Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 108. Mabtech Limited Chronic Urticaria Or Hives Drug Product

Table 109. Mabtech Limited Recent Developments/Updates

Table 110. Merck & Co., Inc. Company Information

Table 111. Merck & Co., Inc. Description and Business Overview

Table 112. Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 113. Merck & Co., Inc. Chronic Urticaria Or Hives Drug Product

Table 114. Merck & Co., Inc. Recent Developments/Updates

Table 115. Mycenax Biotech Inc. Company Information

Table 116. Mycenax Biotech Inc. Description and Business Overview

Table 117. Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 118. Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Product

Table 119. Mycenax Biotech Inc. Recent Developments/Updates

Table 120. Novartis AG Company Information

Table 121. Novartis AG Description and Business Overview

Table 122. Novartis AG Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 123. Novartis AG Chronic Urticaria Or Hives Drug Product

Table 124. Novartis AG Recent Developments/Updates

Table 125. Panacea Biotec Limited Company Information

Table 126. Panacea Biotec Limited Description and Business Overview

Table 127. Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 128. Panacea Biotec Limited Chronic Urticaria Or Hives Drug Product

Table 129. Panacea Biotec Limited Recent Developments/Updates

Table 130. Key Raw Materials Lists

Table 131. Raw Materials Key Suppliers Lists

Table 132. Chronic Urticaria Or Hives Drug Distributors List

Table 133. Chronic Urticaria Or Hives Drug Customers List

Table 134. Chronic Urticaria Or Hives Drug Market Trends

Table 135. Chronic Urticaria Or Hives Drug Market Drivers

Table 136. Chronic Urticaria Or Hives Drug Market Challenges

Table 137. Chronic Urticaria Or Hives Drug Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

Table 141. Authors List of This Report

List of Figures

Figure 1. Product Picture of Chronic Urticaria Or Hives Drug

Figure 2. Global Chronic Urticaria Or Hives Drug Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Chronic Urticaria Or Hives Drug Market Share by Type: 2024 & 2031

Figure 4. GDC-0853 Product Picture

Figure 5. GSK-2646264 Product Picture

Figure 6. BF-Derm-1 Product Picture

Figure 7. Bilastine Product Picture

Figure 8. Others Product Picture

Figure 9. Global Chronic Urticaria Or Hives Drug Market Value by Application (2020-2031) & (US$ Million)

Figure 10. Global Chronic Urticaria Or Hives Drug Market Share by Application: 2024 & 2031

Figure 11. Clinic

Figure 12. Hospital

Figure 13. Others

Figure 14. Global Chronic Urticaria Or Hives Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Chronic Urticaria Or Hives Drug Market Size (2020-2031) & (US$ Million)

Figure 16. Global Chronic Urticaria Or Hives Drug Sales (2020-2031) & (K Pcs)

Figure 17. Global Chronic Urticaria Or Hives Drug Average Price (USD/Pcs) & (2020-2031)

Figure 18. Chronic Urticaria Or Hives Drug Report Years Considered

Figure 19. Chronic Urticaria Or Hives Drug Sales Share by Manufacturers in 2024

Figure 20. Global Chronic Urticaria Or Hives Drug Revenue Share by Manufacturers in 2024

Figure 21. Global 5 and 10 Largest Chronic Urticaria Or Hives Drug Players: Market Share by Revenue in Chronic Urticaria Or Hives Drug in 2024

Figure 22. Chronic Urticaria Or Hives Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 23. Global Chronic Urticaria Or Hives Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 24. North America Chronic Urticaria Or Hives Drug Sales Market Share by Country (2020-2031)

Figure 25. North America Chronic Urticaria Or Hives Drug Revenue Market Share by Country (2020-2031)

Figure 26. U.S. Chronic Urticaria Or Hives Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Canada Chronic Urticaria Or Hives Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Europe Chronic Urticaria Or Hives Drug Sales Market Share by Country (2020-2031)

Figure 29. Europe Chronic Urticaria Or Hives Drug Revenue Market Share by Country (2020-2031)

Figure 30. Germany Chronic Urticaria Or Hives Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. France Chronic Urticaria Or Hives Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. U.K. Chronic Urticaria Or Hives Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Italy Chronic Urticaria Or Hives Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Russia Chronic Urticaria Or Hives Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Asia Pacific Chronic Urticaria Or Hives Drug Sales Market Share by Region (2020-2031)

Figure 36. Asia Pacific Chronic Urticaria Or Hives Drug Revenue Market Share by Region (2020-2031)

Figure 37. China Chronic Urticaria Or Hives Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Japan Chronic Urticaria Or Hives Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. South Korea Chronic Urticaria Or Hives Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. India Chronic Urticaria Or Hives Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Australia Chronic Urticaria Or Hives Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Taiwan Chronic Urticaria Or Hives Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Indonesia Chronic Urticaria Or Hives Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Thailand Chronic Urticaria Or Hives Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Malaysia Chronic Urticaria Or Hives Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Philippines Chronic Urticaria Or Hives Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Latin America Chronic Urticaria Or Hives Drug Sales Market Share by Country (2020-2031)

Figure 48. Latin America Chronic Urticaria Or Hives Drug Revenue Market Share by Country (2020-2031)

Figure 49. Mexico Chronic Urticaria Or Hives Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Brazil Chronic Urticaria Or Hives Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Argentina Chronic Urticaria Or Hives Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Middle East and Africa Chronic Urticaria Or Hives Drug Sales Market Share by Country (2020-2031)

Figure 53. Middle East and Africa Chronic Urticaria Or Hives Drug Revenue Market Share by Country (2020-2031)

Figure 54. Turkey Chronic Urticaria Or Hives Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Saudi Arabia Chronic Urticaria Or Hives Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. U.A.E Chronic Urticaria Or Hives Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. Global Sales Market Share of Chronic Urticaria Or Hives Drug by Type (2020-2031)

Figure 58. Global Revenue Market Share of Chronic Urticaria Or Hives Drug by Type (2020-2031)

Figure 59. Global Chronic Urticaria Or Hives Drug Price (USD/Pcs) by Type (2020-2031)

Figure 60. Global Sales Market Share of Chronic Urticaria Or Hives Drug by Application (2020-2031)

Figure 61. Global Revenue Market Share of Chronic Urticaria Or Hives Drug by Application (2020-2031)

Figure 62. Global Chronic Urticaria Or Hives Drug Price (USD/Pcs) by Application (2020-2031)

Figure 63. Chronic Urticaria Or Hives Drug Value Chain

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Body Washes for Eczema Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0H11490

Wed Feb 26 00:00:00 UTC 2025

Add to Cart

Global Silicone Scar Treatment Gels Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-24I9968

Thu Feb 20 00:00:00 UTC 2025

Add to Cart

Global Dermatology Cryosurgical Equipment Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22A9963

Thu Feb 20 00:00:00 UTC 2025

Add to Cart

Global Dermoscopy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-11S10329

Thu Feb 13 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions